Syndax Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 19.22 USD | 25,59 USD | 9,49 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 39,455 USD | 9 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 88.610.027 | 23,9 | 8,86 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Syndax Pharmaceuticals Inc
Mitarbeiter 298
Handelsplatz NASDAQ
Ticker Symbol SNDX
IPO Datum 2016-03-03
Adresse 730 Third Avenue, New York, NY, United States, 10017
Webseite https://syndax.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Michael A. Metzger M.B.A. | CEO & Director |
| 2 | Mr. Keith Alan Goldan CPA | CFO, Treasurer & Principal Accounting Officer |
| 3 | Mr. Luke J. Albrecht J.D. | Senior VP, General Counsel & Secretary |
| 4 | Mr. Steven Closter | Chief Commercial Officer |
| 5 | Dr. Nicholas A.J. Botwood B.Sc., MBBS | Head of Research & Development and Chief Medical Officer |
| 6 | Dr. Peter Ordentlich B.Sc., Ph.D. | Co-Founder & Chief Scientific Officer |
| 7 | Dr. Richard A. Heyman Ph.D. | Co-Founder |
| 8 | Dr. Ronald M. Evans Ph.D. | Co-Founder, Advisor and Chair of Scientific Advisory Board |
| 9 | Dr. Michael Downes Ph.D. | Co-Founder |
| 10 | Sharon Klahre | Vice President of Investor Relations & Communications |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Kynam Capital Management, LP | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Deerfield Management Co | 0,00% | 0,00 Mio. USD |
| 9 | Eversept Partners, LP | 0,00% | 0,00 Mio. USD |
| 10 | Kingdon Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 11 | StemPoint Capital LP | 0,00% | 0,00 Mio. USD |
| 12 | Hood River Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 13 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Franklin Resources Inc | 0,00% | 0,00 Mio. USD |
| 15 | Point72 Asset Management, L.P. | 0,00% | 0,00 Mio. USD |
| 16 | Elmind Capital LP | 0,00% | 0,00 Mio. USD |
| 17 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 18 | BNP Paribas Investment Partners SA | 0,00% | 0,00 Mio. USD |
| 19 | Soleus Capital Management, L.P. | 0,00% | 0,00 Mio. USD |
| 20 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |